職名 助教
氏名 なかむら ともき
中村 知樹
生年月 1976.06
所属 部局 附属病院
学科・専攻 整形外科
講座  
教育研究分野  
TEL  
FAX  
E-mail tomoki66@clin.medic. (末尾に mie-u.ac.jp を補ってください)
個人のホームページ  
学歴 三重大学医学部 学士課程 (~2002年)
三重大学大学院医学系研究科生命医科学専攻病態解明医学講座 博士課程・博士後期課程 (~2009年) 卒業・修了
学位 医学博士
所属学会 日本整形外科学会
日本がん治療学会
中部日本整形外科災害外科学会
日本サルコーマ治療研究学会
社会活動 ・Journal of Orthopaedic Science, Japanese Journal of Clinical Oncology; Editorial reviewer
・BMC Cancer, PLOS ONE, Oncology Reportsなど:Associate Editor
職歴  
学術(芸術)賞 日本整形外科学会 奨励賞
専門分野 整形外科
現在の研究課題 骨軟部腫瘍
担当科目  
主な業績等 1. Clinical outcome of systemic treatment for advanced soft tissue sarcoma: Real life perspective in Japan. Nakamura T, Asanuma K, Hagi T, Sudo A. Drug Des Devel Ther 2020;14:4215-4220.
2. Standard treatment remains the recommended approach for patients with bone sarcoma who underwent unplanned surgery: Report from the Japanese Musculoskeletal Oncology group. Nakamura T, Sugaya J, Naka N, Kobayashi H, Okuma T, Kunisada T, Asanuma K, Outani H, Nishimura S, Kawashima H, Akiyama T, Yasuda T, Miwa S, Sudo A, Ueda T. Cancer Manag Res 2020;12:10017-10022.
3. Expression of interleukin-6 and the interleukin-6 receptor predicts the clinical outcomes of patients with soft tissue sarcomas. Nakamura K, Nakamura T, Iino T, et al. Cancers(Basel) 2020;12:E585.
4. Vastus lateralis myocutaneous flap for ischial skin wound following the treatment of epithelioid sarcoma using pazopanib. Tsujii M, Matsumine A, Nakamura T, Satonaka H, Sudo A. J Wound Care 2020;29:335-339.
5. Cases of abdominal wall endometriosis distinguished from soft tissue tumors: A report of three cases. Hagi T, Nakamura T, Hasegawa T, Asanuma K, Sudo A. Biomed Rep 2020;13:64.
6. Clinical outcome of latissimus dorsi reconstruction after wide resection of soft tissue sarcoma. Kita K, Nakamura T, Tsujii M, Kato J, Hagi T, Asanuma K, Sudo A. Eur J Orthop Surg Traumatol 2020.
7. Prognostic significance of thrombomodulin mRNA in high-grade soft tissue sarcoma after 10 years. Asanuma K, Nakamura T, Asanuma Y, Okamoto T, Kakimoto T, Yada Y, Hagi T, Kita K, Nakamura K, Matsumine A, Sudo A. Orthop Surg 2020
8. Osteoconductivity bioactive Ti-6Al-4V implants with lattice-shaped interconnected large pores fabricated by electron beam melting. Goto M, Matsumine A, Yamaguchi S, Takahashi H, Akeda K, Nakamura T, Asanuma K, Matsushita T, Kokubo T, Sudo A. J Biomater Appl 2020.
9. Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas. Asanuma K, Nakamura T, Hayashi A, Okamoto T, Iino T, Asanuma Y, Hagi T, Kita K, Nakamura K, Sudo A. Sci Rep 2020;10:9077.
10. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Heng M, Gupta A, Chung PW, JMOG et al. Eur J Cancer 2020; 125: 130-141.
11. Is serum lactate dehydrogenase useful for predicting oncological outcome in patients with soft tissue sarcoma? Nakamura T, Asanuma K, Hagi T, Sudo A. Anticancer Res 2019;39:6871-6875.
12. The clinical outcome of hemicortical extracorporeal irradiated autologous bone graft after tumor resection of bone and soft tissue sarcoma. Nakamura T, FujiwaraT, Tsuda Y et al. Anticancer Res 2019; 39: 5605-5610,
13. Inhibitory effect of edaravone on systemic inflammation and local damage in skeletal muscles following long-term ischemia to murine hind limb. J Orthop Surg (Hong Kong) 2019; 27: 2309499019874470.
14. The clinical outcomes of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study. Nakamura T, Tsukushi S, Asanuma K, Katagiri H, Ikuta K, Nagano A, Kozawa E, Yamada S, Shido Y, Yamada K, Kawanami K, Ishimura D, Sudo A, Nishida Y. Clin Exp Metastasis 2019; 36: 343-350.
15. Localized synovial sarcoma: A single institutional study of 191 patients with a minimum follow-up of 5 years for survivors. Outani H, Nakamura T, Murata H, Stevenson J, Parry M, Gregory J, Tillman R, Jeys L, Abudu A. J Surg Oncol 2019; 119: 850-855.
16. Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol. Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H. BMC Musculoskelet Discord 2019;20:68.
17. Serum thrombomodulin as a metastatic and prognostic marker in soft tissue sarcomas. Asanuma K, Nakamura T, Asanuma Y, Kakimoto T, Yada Y, Hagi T, Kita K, Matsumine A, Sudo A. Cancer Biomark 2019 doi:10.3233/CBM-182075.
18. Acute pancreatitis dur to pancreatic metastasis of osteosarcoma: report of two cases. Yoshida K, Nakamura T et al. Ann Joint 2019; 4: 41.
19. The clinical outcomes of total femur prosthesis in patients with musculoskeletal tumors. Kakimoto T, Matsumine A, Asanuma K, Matsubara T, Nakamura T, Sudo A. SICOT J 2019;5:23.
20. Tumor resection may improve survival in patients with soft tissue sarcoma aged 75 years and older. Nakamura T, Oi T, Asanuma K, Hagi T, Sudo A. Anticancer Res 2019; 39: 331-334.
21. Successful treatment with cryoablation in a patient with bone metastasis in mid-shaft femur: a case report. Kita K, Nakamura T, Yamanaka T, Yoshida K, Hagi T, Asanuma K, Nakatsuka A, Sudo A. Onco Targets Ther.2019; 12: 2949-2953.
22. Soft tissue sarcoma at adductor compartment of the thigh may have a great risk of tumor-associated events and wound complications. Nakamura T, Nakamura K, Hagi T, Asanuma K, Sudo A. J Orthop Surg (Hong Kong) 2019; 27: 2309499019840813.
23. Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma. Kakimoto T, Matsumine A, Kageyama S, Asanuma K, Matsubara T, Nakamura T, Iino T, Ikeda H, Shiku H, Sudo A. Oncol Lett 2019; 17: 3937-3943.
24. Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma. Okuno K, Matsubara T, Nakamura T, Iino T, Kakimoto T, Asanuma K, Matsumine A, Sudo A. Onco Targets Ther 2018; 11: 6879-6886.
25. Intra-articular synovial sarcoma in the ankle joint: A case report. Nakamura T, Hagi T, Asanuma K, Sudo A. Mol Clin Oncol 2018; 9: 464-466.
26. Long-term clinical outcome in patients with high-grade soft tissue sarcoma who were treated with surgical adjuvant therapy using acridine orange after intra-lesional or marginal resection. Nakamura T, Kusuzaki K, Matsubara T, et al. Photodiagnosis Photodyn Ther 2018; 23: 165-170.
27. Is FDG-PET/CT useful for diagnosing pulmonary metastasis in patients with soft tissue sarcoma? Hagi T, Nakamura T, Sugino Y et al. Anticancer Res 2018; 38(6): 3635-3639.
28. Interleukin-6 receptor inhibitor suppress bone metastases in a breast cancer cell line. Wakabayashi H, Hamaguchi T, Nagao N, Kato S, Iino T, Nakamura T, Sudo A. Breast Cancer 2018; 25: 566-574.
29. Analysis of the patients with soft tissue sarcoma who received additional excision after unplanned excision: report from the Bone and Soft Tissue Tumor Registry in Japan. Nakamura T, Kawai A, Sudo A. Jpn J Clin Oncol 2017;47:1055-1059.
30. The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas. Hagi T, Nakamura T, Iino T et al. Sci Rep 2017; 7: 9640.
31. Analysis of the infiltrative features of chordoma: The relationship between micro-skip metastasis and postoperative outcomes. Akiyama T, Ogura K, Gokita T, Nakamura T et al. Ann Surg Oncol 2018; 25: 912-919.